Combining pharmacotherapy with structured support maximizes success rates and addresses both the neurochemical and behavioral dimensions of nicotine dependence
(E(X)-4)(2)-Fc, an effective long-acting GLP-1 receptor agonist, reduces obesity-related inflammation by inhibiting leptin expression
Those with certain medical conditions or taking specific medications should discuss alternatives with their healthcare provider
Adiposity and cancer risk: new mechanistic insights from epidemiology
doi:10.1016/j.freeradbiomed.2010.11.029, S0891-5849(10)01401-2 [pii] Levonen AL, Hill BG, Kansanen E, Zhang J, Darley-Usmar VM (2014) Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics
Frequently Asked Questions Will UnitedHealthcare definitely deny my GLP-1 request for weight loss